
At Antidote, we bring together talented people with pharmaceutical, technology, business, and public health backgrounds to achieve an important mission. Along the way, we manage to have some fun, too.

As a digital patient engagement company, Antidote’s focus is on connecting patients to clinical trials — that’s why we have a moral imperative to support diversity, equity, and inclusion (DEI) initiatives that ensure clinical trial populations reflect those of the real world. As such, we support and conduct our business by the following tenets related to DEI:
Antidote’s environmental, social, and corporate governance efforts demonstrate our commitment to do well by doing good. We aim to be responsible stewards of the environment, good citizens of the world, and embracers of corporate transparency and accountability. Through quarterly awareness campaigns, annual volunteer days, and ongoing employee training opportunities, we are being intentional about our efforts to make a positive impact on our communities and our world.
We are honored to have received the Silver Award from Ecovadis, the world’s only universal sustainability rating provider, for two years in a row. The Silver Award denotes that Antidote is in the top 25% of 90,000 companies across 160 countries assessed for their commitment to CSR in 2022 and 2023.
.webp)